Clinical Pharmacology of Antipsychotic Drugs
- 1 January 1989
- journal article
- review article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 17 (1) , 1-16
- https://doi.org/10.1177/030006058901700101
Abstract
Antipsychotic drugs are widely used to treat abnormal behaviour particularly that related to the functional psychoses such as schizophrenia. This review discusses the pharmacokinetics and pharmacology of antipsychotic drugs like chlorpromazine. Clinical use comprises the induction of tranquillization in disturbed psychiatric patients, the treatment of acute and chronic schizophrenic symptoms, and the postponement of relapse in such patients. Unwanted effects are multifarious, involving many systems of the body. Extrapyramidal signs and symptoms are particularly noticeable, and the chronic type, tardive dyskinesia, is a major problem.Keywords
This publication has 63 references indexed in Scilit:
- Haloperidol DecanoateDrugs, 1987
- Clinical Pharmacokinetics of the Depot AntipsychoticsClinical Pharmacokinetics, 1985
- Neuroleptic malignant syndrome.BMJ, 1984
- Treatment Outlines for the Management of SchizophreniaAustralian & New Zealand Journal of Psychiatry, 1984
- Management of Tardive DyskinesiaDrugs, 1982
- The Role of Maintenance Therapy and Relatives' Expressed Emotion in Relapse of Schizophrenia: A Two-Year Follow-upThe British Journal of Psychiatry, 1981
- Adverse Effects of Antipsychotic AgentsDrugs, 1981
- Discontinuing antiparkinson medication in chronic schizophrenicsActa Psychiatrica Scandinavica, 1981
- Time to evaluate long-acting neuroleptics?Psychological Medicine, 1975
- A critical review of some published experiments with chlorpromazine in schizophrenic, neurotic, and normal humansJournal of Chronic Diseases, 1960